The global membrane oxygenators market, valued at USD 132.1 million in 2024, is projected to grow at a CAGR of 2.2% from 2025 to 2034. The increasing prevalence of respiratory and cardiac disorders, including conditions like ARDS, cardiogenic shock, and myocarditis, drives the demand for advanced oxygenation systems, with membrane oxygenators being essential. Additionally, the growing geriatric population, more susceptible to these conditions, further boosts market growth. Technological advancements, such as hollow fiber membranes that improve gas exchange efficiency, also contribute to their expanding adoption in clinical settings.
Another driver is the growing utilization of extracorporeal membrane oxygenation (ECMO) therapy in critical care, particularly during emergencies like acute myocardial infarctions or post-transplant complications. The COVID-19 pandemic also highlighted the importance of membrane oxygenators in managing severe respiratory failure cases, significantly boosting market awareness and adoption.
Increased healthcare spending in developing nations, coupled with the expansion of advanced healthcare infrastructure, has further propelled market growth. Government initiatives to improve healthcare access and increasing training for ECMO deployment are also encouraging the use of membrane oxygenators.
Moreover, the development of portable and user-friendly systems is expanding the application of these devices in neonatal and pediatric care. With these innovations and an emphasis on improving patient outcomes, the membrane oxygenators industry is poised for substantial growth over the coming years.
Membrane oxygenators are medical devices used in extracorporeal life support to facilitate gas exchange by removing carbon dioxide and delivering oxygen to the blood. Utilizing advanced membrane technologies like hollow fibers or flat sheets, they are essential in managing respiratory and cardiac failures, especially during ECMO procedures and critical care interventions.
The rising prevalence of cardiovascular diseases (CVDs) is a significant driver of the global membrane oxygenators industry. CVDs, including coronary artery disease, heart failure, and myocardial infarction, have become leading causes of mortality worldwide. According to the World Health Organization (WHO), an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths, with an increasing incidence in both developed and developing countries.
Based on type, the market is bifurcated as hollow fiber membrane oxygenators and flat sheet membrane oxygenators. The hollow fiber membrane oxygenators segment is expected to drive business growth and expand at a CAGR of 2.6%, reaching over USD 100.6 million by 2034.
Based on application, the membrane oxygenators market is segmented as respiratory, cardiac, and extra corporeal cardiopulmonary resuscitation. The respiratory segment is expected to drive business growth and expand at a CAGR of 1.9%, reaching over USD 72.5 million by 2034.
Based on age group, the market is segmented as adults, neonates, and pediatrics. The adults segment is expected to drive business growth and expand at a CAGR of 2.7%, reaching over USD 108.4 million by 2034.
Based on end use, the membrane oxygenators market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 43.9% in 2024.
U.S. membrane oxygenators market accounted for USD 44.2 million in 2024 and is anticipated to grow at a CAGR of 1.4% between 2025 to 2034 period.
UK market is projected to grow remarkably in the coming years.
China holds a dominant position in the Asia Pacific membrane oxygenators market.
The global membrane oxygenators industry features a mix of established players and emerging manufacturers, competing in a dynamic landscape driven by innovation and demand for advanced extracorporeal life-support systems. Leading companies account for a significant market share due to their robust portfolios, strong distribution networks, and investments in research and development. Market share is further influenced by strategic initiatives such as product launches, collaborations, and geographic expansion. Local manufacturers are gaining traction in cost-sensitive regions by offering affordable, high-quality products.
Prominent players operating in the membrane oxygenators industry include: